| RENTRAK CORPORATION | ||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | ||||
| (UNAUDITED) | ||||
| Dec 31 | March 31, | |||
| 2004 | 2004 | |||
| ASSETS | ||||
| CURRENT ASSETS: | ||||
| Cash and cash equivalents | $ 18,210,464 | $ 8,735,683 | ||
| Accounts receivable, net of allowance for doubtful | ||||
| accounts of $935,256 and $839,122 | 15,850,554 | 15,389,867 | ||
| Advances to program suppliers, net of program | ||||
| supplier reserves of $4,326,284 and $4,520,759 | 1,709,436 | 4,188,222 | ||
| Income tax receivable | 87,435 | 68,384 | ||
| Deferred tax asset | 1,772,387 | 2,262,186 | ||
| Other current assets | 1,059,910 | 1,160,952 | ||
| Total current assets | 38,690,186 | 31,805,294 | ||
| PROPERTY AND EQUIPMENT, net | 3,038,507 | 2,466,668 | ||
| DEFERRED TAX ASSET | 208,566 | 1,099,660 | ||
| OTHER ASSETS | 962,829 | 831,617 | ||
| TOTAL ASSETS | $ 42,900,088 | $ 36,203,239 | ||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||
| CURRENT LIABILITIES: | ||||
| Accounts payable | $ 12,395,974 | $ 15,446,818 | ||
| Accrued liabilities | 1,411,726 | 889,377 | ||
| Accrued compensation | 1,114,541 | 598,875 | ||
| Deferred revenue | 445,250 | 237,575 | ||
| Total current liabilities | 15,367,491 | 17,172,645 | ||
| LONG-TERM LIABILITIES: | ||||
| Lease obligations and deferred gain | 101,718 | 234,922 | ||
| COMMITMENTS AND CONTINGENCIES | - | - | ||
| STOCKHOLDERS' EQUITY: | ||||
| Preferred stock, $.001 par value; | ||||
| Authorized: 10,000,000 shares, none issued | - | - | ||
| Common stock, $.001 par value; | ||||
| Authorized: 30,000,000 shares | ||||
| Issued and outstanding: 10,297,776 shares | ||||
| at Sept 30, 2004 and 9,739,537 at | ||||
| March 31, 2003 | 10,298 | 9,740 | ||
| Capital in excess of par value | 45,245,936 | 41,093,976 | ||
| Accumulated other comprehensive income | 180,879 | 180,879 | ||
| Accumulated deficit | (18,006,234) | (22,488,923) | ||
| Total stockholders' equity | 27,430,879 | 18,795,672 | ||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 42,900,088 | $ 36,203,239 | ||
| The accompanying notes are an integral part of these consolidated statements. | ||||